Analysts have been lifting fair value estimates for Krystal Biotech, with the updated Street number moving from US$291.22 to US$315.00, roughly a US$24 shift in the latest models. That change lines up ...

A biotechnology company has developed "what could turn out to be one of the most important cancer drugs in a generation," ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

While several major biotech companies are laying off employees by the hundreds, one is dropping billions in acquisitions.

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...

The 552 million pounds ($747 million) raised by British biotechs in the first quarter of the year has been hailed as a “sign ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

Altitude Labs, an offshoot of AI-focused techbio Recursion, is teaching scientists to build companies, one founder at a time.

Dallas‑based Colossal Biosciences, known for its woolly mammoth work, has announced its next de‑extinction effort—aiming to ...